1. Home
  2. ROIV vs TECK Comparison

ROIV vs TECK Comparison

Compare ROIV & TECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$38.91

Market Cap

28.7B

Sector

Health Care

ML Signal

N/A

Logo Teck Resources Ltd

TECK

Teck Resources Ltd

N/A

Current Price

$48.70

Market Cap

32.4B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ROIV
TECK
Founded
2014
1913
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
32.4B
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
ROIV
TECK
Price
$38.91
$48.70
Analyst Decision
Strong Buy
Hold
Analyst Count
13
17
Target Price
$50.82
★ $60.84
AVG Volume (30 Days)
★ 7.1M
2.9M
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
★ 0.70%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $8,260,000.00
N/A
Revenue This Year
$1,870.25
$45.29
Revenue Next Year
$271.46
$1.64
P/E Ratio
★ N/A
$32.94
Revenue Growth
N/A
★ N/A
52 Week Low
$19.96
$39.51
52 Week High
$42.50
$72.56

Technical Indicators

Market Signals
Indicator
ROIV
TECK
Relative Strength Index (RSI) 54.07 27.46
Support Level $33.11 $48.34
Resistance Level $42.37 $67.93
Average True Range (ATR) 1.55 2.18
MACD -0.07 -1.27
Stochastic Oscillator 49.40 1.18

Price Performance

Historical Comparison
ROIV
TECK

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About TECK Teck Resources Ltd

Teck is a base metals miner with copper and zinc operations in Canada, the United States, Chile, and Peru. After selling its metallurgical coal business, copper is now its major commodity by EBITDA contribution, followed by zinc. Teck is a top-three zinc miner. Its major new copper mine in Chile at the majority-owned Quebrada Blanca 2, in partnership with Sumitomo, will drive an increase in Teck's attributable copper production by roughly 80%. Along with a number of additional copper growth options, Teck's strategy is to rebalance its portfolio to low-carbon metals such as copper. It sold its oil sands business in early 2023 and its coal business in mid-2024. In September 2025, it agreed to merge with Anglo American in an all-equity deal.

Share on Social Networks: